EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency



Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency



Blood 97(3): 809-811



Bone marrow transplantation (BMT) for severe combined immunodeficiency (SCID) with human leukocyte antigen (HLA)-identical sibling donors but no pretransplantation cytoreduction results in T-lymphocyte engraftment and correction of immune dysfunction but not in full hematopoietic engraftment. A case of a 17-month-old girl with adenosine deaminase (ADA) deficiency SCID in whom full hematopoietic engraftment developed after BMT from her HLA-identical sister is reported. No myeloablative or immunosuppressive therapy or graft-versus-host disease (GVHD) prophylaxis was given. Mild acute and chronic GVHD developed, her B- and T-cell functions became reconstituted, and she is well almost 11 years after BMT. After BMT, repeated studies demonstrated: (1) Loss of a recipient-specific chromosomal marker in peripheral blood leukocytes (PBLs) and bone marrow, (2) conversion of recipient red blood cell antigens to donor type, (3) conversion of recipient T-cell, B-cell, and granulocyte lineages to donor origin by DNA analysis, and (4) increased ADA activity and metabolic correction in red blood cells and PBLs.

(PDF emailed within 1 workday: $29.90)

Accession: 010684791

Download citation: RISBibTeXText

PMID: 11157502



Related references

Hematopoietic engraftment following allogeneic bone marrow transplant without cytoreduction in a child with severe combined immune deficiency. Blood 82(10 SUPPL 1): 644A, 1993

Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency. Blood 84(11): 3936-3947, 1994

The use of locus-specific minisatellite probes to check engraftment following allogeneic bone marrow transplantation for severe combined immunodeficiency disease. Bone Marrow Transplantation 5(3): 199-204, 1990

Stable engraftment of allogeneic t cells in a patient with severe combined immunodeficiency recognition of host histocompatibility antigens and engraftment failure of a bone marrow transplant hla identical to the host. Journal of Cellular Biochemistry Supplement (14 PART A): 297, 1990

Stable engraftment of allogeneic t lymphocytes in a patient with severe combined immunodeficiency following a transfusion with unirradiated blood specific recognition of host histocompatibility antigens and engraftment failure of a bone marrow transplant hla identical to the host. Transplantation (Baltimore) 51(4): 818-824, 1991

Allogeneic bone marrow transplantation in severe combined immunodeficiency. Immunitaet und Infektion 13(6): 245-248, 1985

Rapid detection of engraftment using T cell receptor gene polymorphism after allogeneic bone marrow transplantation in an alloimmunized child with severe aplastic anemia. Bone Marrow Transplantation 12(6): 661-664, 1993

Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion. Stem Cells 22(2): 125-134, 2004

Marrow content of progenitor cells and hematopoietic engraftment after allogeneic and autologous bone marrow transplantation. Bone Marrow Transplantation 0(PROGRAM ABSTR ): 110, 1994

Chimerism and immune reconstitution following allogeneic bone marrow transplantation for severe combined immunodeficiency disease. Immunodeficiency 4(1-4): 311-313, 1993

Telomere Length after Allogeneic Bone Marrow Transplantation in Children with Severe Combined Immunodeficiency Disease. Blood 100(11): Abstract No 2414, November 16, 2002

Subtyping of erythrocyte phosphoglucomutase-1 as a genetic marker for bone-marrow engraftment and hematopoietic chimerism after allogeneic bone-marrow transplantation in a patient with acute lymphoblastic leukemia. Clinical Chemistry 34(12): 2586-2588, 1988

Severe combined immunodeficiency. Successful bone marrow transplantation from father to child. Ugeskrift for Laeger 141(32): 2169-2172, 1979